Chargement en cours...
An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases
Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. Omalizumab is the unique biologic treatment registered for asthma therapy in children. The clinical efficacy and safety of omalizumab treatment in the pediatric population has been extensively...
Enregistré dans:
| Publié dans: | Curr Respir Med Rev |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bentham Science Publishers
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735517/ https://ncbi.nlm.nih.gov/pubmed/29290750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1573398X13666170616110738 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|